World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26183
World Ranking
15085
National Ranking
796

Overview

Günter Henze is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on medical fields related to hematology, pediatrics, oncology, and public health. The scientist has made multiple contributions to the study of acute lymphoblastic leukemia (ALL) and other hematologic malignancies, with a career marked by publications addressing treatment strategies and disease outcomes.

The areas of study covered by their work include:

  • Medicine
  • Public Health, Environmental and Occupational Health
  • Hematology
  • Pediatrics, Perinatology and Child Health
  • Pathology and Forensic Medicine
  • Oncology

Their research topics involve:

  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Neutropenia and Cancer Infections
  • Hematopoietic Stem Cell Transplantation

Some of the frequent co-authors who have collaborated with Günter Henze include:

  • А. М. Попов
  • Natalia Ponomareva
  • G. А. Novichkova
  • Alexander Karachunskiy
  • Svetlana Lagoyko

Publishing mainly in notable journals, Günter Henze has contributed to:

  • Leukemia
  • Journal for ImmunoTherapy of Cancer
  • Pediatric Hematology/Oncology and Immunopathology

Notable recent papers by this researcher include:

  • Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL, 2024, Journal for ImmunoTherapy of Cancer
  • Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results, 2022, Pediatric Hematology/Oncology and Immunopathology
  • Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial, 2023, Leukemia
  • Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study, 2024, Leukemia

Best Publications

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

    Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott

  • Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

    A Reiter;M Schrappe;WD Ludwig;W Hiddemann

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

    M Schrappe;A Reiter;M Zimmermann;J Harbott

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Alfred Reiter;Martin Schrappe;Markus Tiemann;Wolf-Dieter Ludwig

  • Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

    Thomas Völker;Timm Denecke;Ingo Steffen;Daniel Misch

  • Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

    Frank Berthold;Joachim Boos;Stefan Burdach;Rudolf Erttmann

  • Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

    Peter Bader;Hermann Kreyenberg;Günter H.R. Henze;Cornelia Eckert

  • Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

    Alfred Reiter;Martin Schrappe;Wolf-Dieter Ludwig;Markus Tiemann

  • Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer

  • Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.

    A Reiter;M Schrappe;R Parwaresch;G Henze

  • Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.

    Gunter Henze;Rudiger Fengler;Reinhard Hartmann;Bernhard Kornhuber

  • Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

    Gesche Tallen;Richard Ratei;Georg Mann;Gertjan Kaspers

  • [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].

    H. Riehm;A. Reiter;M. Schrappe;F. Berthold

  • Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87

    Hagen Graf Einsiedel;Arend von Stackelberg;Reinhard Hartmann;Rüdiger Fengler

  • Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.

    Lutz Löning;Martin Zimmermann;Alfred Reiter;Peter Kaatsch

  • Results of Treatment for Soft Tissue Sarcoma in Childhood and Adolescence: A Final Report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

    Ewa Koscielniak;Dieter Harms;Günter Henze;Herbert Jürgens

  • Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

    Peter Bader;Hermann Kreyenberg;Walter Hoelle;Gregor Dueckers

Frequent Co-Authors

Helmut Gadner
Helmut Gadner St Anna Children's Hospital
Martin Schrappe
Martin Schrappe Kiel University
Alfred Reiter
Alfred Reiter University of Giessen
Dietrich Niethammer
Dietrich Niethammer University of Tübingen
Martin Zimmermann
Martin Zimmermann Hannover Medical School
Charlotte M. Niemeyer
Charlotte M. Niemeyer University of Freiburg
Thomas Klingebiel
Thomas Klingebiel Goethe University Frankfurt
Norbert Graf
Norbert Graf Saarland University
Jochen Harbott
Jochen Harbott University of Giessen
Frank Berthold
Frank Berthold University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens doors to a range of related online degrees and professional pathways. Many students consider alternative options that offer flexible study, faster completion times, or entry points into different areas of healthcare.

For those seeking an expedited route to nursing, fast track lpn programs online provide a practical route to licensure as a Licensed Practical Nurse in less time. If you are interested in advanced nursing roles, check out online pmhnp programs, which prepare registered nurses for specialized work in psychiatric and mental health care.

Careers in healthcare administration are also in high demand. For future leaders, the best online mha programs deliver in-depth management training, while options like affordable online mha programs help students pursue their goals within budget.

These alternative educational pathways can complement or provide stepping stones toward a medical degree, depending on your interests and career ambitions.

Best Scientists Citing Günter Henze

Trending Scientists